Skip to main content

Table 1 Patients characteristics

From: Impact of bileaflet mitral valve prolapse on quantification of mitral regurgitation with cardiac magnetic resonance: a single-center study

  All patients (n = 35) No MR (n = 15) Significant MR (n = 20) p
Age (years) 44.0 ± 23.0 38.1 ± 19.1 48.5 ± 25.1 0.19
Height (cm) 174.5 ± 12.4 178.1 ± 13.2 171.9 ± 11.4 0.14
Weight (kg) 62.4 ± 15.9 64.5 ± 18.8 60.8 ± 13.7 0.5
BMI (kg/m2) 20.3 ± 3.8 20.1 ± 4.3 20.4 ± 3.4 0.82
LVEDV (ml) 155.4 ± 51.1 151.5 ± 58.3 158.4 ± 46.3 0.7
LVEDV index (ml/m2) 88.5 ± 22.8 83.4 ± 22.6 92.2 ± 22.8 0.27
LVESV uncorrected (ml) 53.3 ± 23.3 50.9 ± 25.6 55.0 ± 22.0 0.62
LVESV corrected (ml) 69.8 ± 28.4 65.3 ± 29.7 73.1 ± 27.8 0.43
LVEF standard (%) 66.4 ± 7.3 67.2 ± 7.1 65.7 ± 7.6 0.56
LVEF corrected (%) 55.6 ± 8.3 57.6 ± 7.2 54.1 ± 8.9 0.22
Prolapsed height (mm) 8.1 ± 2.8 7.6 ± 2.1 8.5 ± 3.2 0.32
Prolapsed volume (ml) 16.5 ± 8.7 14.4 ± 7.0 18.1 ± 9.6 0.22
RVEDV (ml) 140.1 ± 46.3 157.4 ± 55.6 127.2 ± 33.8 0.05
RVESV (ml) 68.6 ± 24.5 73.8 ± 28.7 64.7 ± 20.9 0.29
RVEF (%) 51.0 ± 6.6 53.5 ± 5.3 49.1 ± 7.0 0.05
Indication for CMR (n; %)
• Marfan syndrome 11 (31) 6 (40) 5 (25) 0.02
• MR quantification 9 (26) 0 (0) 9 (45)  
• Ventricular arrhythmia 7 (20) 6 (40) 1 (5)  
• Ischemia detection 5 (14) 2 (13) 3 (15)  
• Suspicion of myocarditis 1 (3) 0 (0) 1 (5)  
• Malformation syndromes 2 (6) 1 (7) 1 (5)